sever
acut
respiratori
syndrom
coronaviru
sarscov
pose
consider
threat
human
health
activ
viral
spike
protein
host
cell
proteas
essenti
viral
infect
howev
cleavag
site
sarss
proteas
activ
sarss
incomplet
defin
found
dispens
sarssdriven
viruscel
fusion
sarssactiv
trypsin
cathepsin
l
virusviru
fusion
assay
mutat
optim
minim
furin
consensu
motif
furin
overexpress
augment
sarss
activ
result
detect
sarss
cleavag
final
sarssdriven
cellcel
fusion
independ
cathepsin
l
proteas
essenti
viruscel
fusion
instead
far
unknown
leupeptinsensit
host
cell
proteas
activ
cellular
sarss
fusion
target
cell
express
high
level
thu
differ
host
cell
proteas
activ
sarss
viruscel
cellcel
fusion
sarss
cleavag
dispens
sarss
activ
novel
coronaviru
cov
identifi
caus
agent
sever
acut
respiratori
syndrom
sar
claim
almost
live
drosten
et
al
ksiazek
et
al
peiri
et
al
coronavirus
includ
sarscov
harbour
three
envelop
protein
spike
membran
envelop
e
requir
virion
assembl
releas
infecti
entri
target
cell
master
sarscovsprotein
sarss
mediat
infecti
cellular
entri
hofmann
et
al
simmon
et
al
yang
et
al
constitut
major
target
neutral
antibodi
respons
nie
et
al
nie
et
al
carboxypeptidas
angiotensinconvert
enzym
use
sarscov
receptor
cell
entri
li
et
al
wang
et
al
express
type
ii
pneumocyt
major
viral
target
cell
ham
et
al
mossel
et
al
et
al
sever
cellular
ctype
lectin
augment
facilit
sarssdriven
entri
gramberg
et
al
jeffer
et
al
marzi
et
al
yang
et
al
howev
ctype
lectin
express
correl
suscept
sarssdriven
infect
hofmann
et
al
nie
et
al
essenti
sarscov
spread
experiment
infect
mice
kuba
et
al
indic
major
like
receptor
use
sarscov
infect
host
collect
sarss
interact
host
cell
factor
mediat
first
essenti
step
viral
life
cycl
viru
entri
target
cell
constitut
attract
target
prevent
therapeut
approach
sarssprotein
synthes
constitut
secretori
pathway
infect
cell
amino
acid
motif
cytoplasm
tail
slow
transit
golgi
compart
mcbride
et
al
interact
mprotein
facilit
virion
incorpor
mcbride
macham
voss
et
al
structur
organ
sarss
similar
sever
viral
envelop
protein
term
class
fusion
protein
extracellular
domain
facilit
bind
receptor
membraneanchor
domain
harbour
function
element
requir
fusion
viral
target
cell
membran
viral
class
fusion
protein
usual
synthes
inact
form
requir
activ
host
cell
proteas
transit
fusionact
state
eckert
kim
harrison
howev
viral
strategi
accomplish
proteolyt
activ
vari
instanc
major
strain
murin
coronaviru
mous
hepat
viru
mhv
contain
sprotein
cleav
furin
infect
cell
virus
believ
enter
target
cell
receptordepend
phindepend
fusion
plasma
membran
de
haan
et
al
nash
buchmeier
qiu
et
al
although
find
controversi
eifart
et
al
contrast
sprotein
mhv
type
strain
cleav
furin
spike
protein
incom
virion
activ
target
cell
vesicl
endosom
proteas
cathepsin
famili
qiu
et
al
similar
proteolyt
activ
sarss
mediat
cathepsin
target
cell
importantli
cathepsin
l
simmon
et
al
cleavageactiv
cathepsin
l
thought
requir
previou
bind
sarss
believ
induc
conform
chang
sprotein
simmon
et
al
seem
involv
least
two
consecut
proteolyt
process
step
belouzard
et
al
simmon
et
al
howev
cleavag
site
sarss
incomplet
defin
arginin
shown
requir
robust
augment
sarssdriven
cellcel
belouzard
et
al
folli
et
al
viruscel
fusion
kam
et
al
trypsin
trypsindepend
circumvent
entri
blockad
impos
lysosomotrop
agent
belouzard
et
al
spite
result
present
unknown
requir
sarss
activ
cathepsin
l
recent
evid
suggest
compon
second
cleavag
site
belouzard
et
al
watanab
et
al
thu
similar
residu
demonstr
requir
trypsindepend
augment
sarssdepend
membran
fusion
trypsindepend
resist
lysosomotrop
agent
belouzard
et
al
nevertheless
effici
proteolyt
process
wildtyp
sarss
site
site
far
demonstr
cell
hofmann
et
al
simmon
et
al
xiao
et
al
yang
et
al
yao
et
al
one
except
wu
et
al
notabl
sarssprotein
contain
minim
furin
cleavag
site
posit
rntr
peptid
compris
sequenc
effici
cleav
furin
bergeron
et
al
howev
contribut
rntr
motif
proteolyt
activ
sarss
unknown
order
explor
role
minim
furin
cleavag
site
posit
investig
import
proteas
sensit
site
posit
analyz
sarss
mutant
analysi
reveal
requir
respons
trypsintreat
experiment
system
effect
sarss
activ
trypsin
cathepsin
l
virusviru
fusion
assay
adequ
mimic
isol
condit
requir
sarssdriven
membran
fusion
suggest
might
play
major
role
sarss
activ
target
cell
mutat
optim
exist
minim
furin
cleavag
motif
increas
sarss
activ
evid
cleavag
mutant
obtain
final
result
demonstr
cathepsin
l
activ
sarss
viruscel
cellcel
fusion
depend
activ
far
uncharacter
serin
proteas
fusion
target
express
high
amount
addit
exogen
trypsin
fusion
target
express
low
amount
base
align
coronavirus
suggest
residu
defin
potenti
cleavag
site
host
cell
proteas
bergeron
et
al
folli
et
al
determin
import
residu
sarss
sensit
proteolysi
introduc
mutat
wt
sarss
fig
analysi
sarss
mutant
lentivir
pseudotyp
experiment
approach
adequ
model
sarssdriven
entri
target
cell
hofmann
et
al
moor
et
al
simmon
et
al
show
mutat
compat
robust
sarssdriven
virion
incorpor
entri
fig
b
albeit
entri
effici
virus
harbour
mutant
sprotein
somewhat
reduc
compar
pseudotyp
bear
wt
sarss
fig
similar
result
seen
doubl
mutant
wt
sarss
count
per
second
cp
cp
demonstr
particular
basic
residu
requir
infecti
entri
tissu
cultur
next
assess
exchang
alter
sensit
sarssbear
pseudotyp
trypsin
treatment
previous
shown
inactiv
cellfre
virion
simmon
et
al
inde
pretreat
pseudotyp
bear
wt
sarss
sarss
mutant
reduc
viral
infect
dosedepend
manner
fig
contrast
sarss
mutant
resist
inactiv
trypsin
fig
c
indic
defin
trypsinsensit
site
cleavag
site
abrog
infect
free
virion
character
import
sarss
sensit
proteolysi
compar
pseudotyp
bear
wt
sarss
sarss
mutant
sensit
inactiv
panel
proteas
treatment
trypsin
plasmin
factor
xa
lesser
extent
thrombin
reduc
infect
virus
harbour
wt
sarss
sarss
mutant
fig
underlin
defin
proteas
sensit
site
thermolysin
chymotrypsin
treatment
also
diminish
viral
infect
wt
sarss
sarss
mutant
equal
sensit
inactiv
proteas
fig
indic
cleav
sarss
site
distinct
collect
defin
proteasesensit
site
proteolysi
cellfre
virion
site
abrog
viral
infect
lysosomotrop
agent
ammonium
chlorid
interfer
endosom
acidif
block
infecti
entri
sarscov
hofmann
et
al
simmon
et
al
yang
et
al
presum
inhibit
cathepsin
requir
low
ph
optim
activ
treatment
cellbound
viru
trypsin
shown
allow
infecti
sarssdriven
entri
ammonium
chloridetr
cell
simmon
et
al
indic
trypsin
function
replac
cathepsin
l
sarssactiv
proteas
condit
trypsin
bypass
ask
requir
trypsin
bypass
endosom
acidif
treatment
target
cell
ammonium
chlorid
markedli
inhibit
infecti
entri
driven
wt
sarss
sarss
mutant
infect
wt
sarssbear
virus
could
fulli
restor
treatment
cellbound
virion
trypsin
fig
contrast
infect
bear
virion
rescu
trypsin
treatment
fig
indic
requir
activ
cellbound
virion
trypsin
next
assess
impact
sarss
proteolyt
activ
virusviru
membranefus
assay
assay
sarssbear
virus
also
contain
avian
sarcoma
leukosi
virusa
envelop
protein
enva
membran
allow
fuse
harbour
virus
fusion
effici
quantifi
addit
virion
leupeptintr
exclud
impact
host
cell
proteas
sarss
activ
hela
cell
express
enva
receptor
tva
suscept
sarssdriven
infect
simmon
et
al
thu
virusviru
fusion
assay
reductionist
model
system
allow
proteolyt
activ
sarss
proceed
cellfre
condit
effici
fusion
virion
bear
wt
sarss
virion
bear
observ
upon
treatment
particl
trypsin
recombin
activ
cathepsin
l
fig
agreement
previous
report
result
simmon
et
al
strikingli
trypsin
cathepsin
l
treatment
activ
virion
bear
wt
sarss
sarss
mutant
similar
effici
fig
demonstr
dispens
sarss
activ
condit
summari
defin
trypsin
cleavag
site
respons
trypsindepend
activ
cellbound
inactiv
cellfre
virion
respect
howev
dispens
tissu
cultur
infect
sarss
activ
trypsin
cathepsin
l
virionvirion
fusion
assay
might
thu
dispens
proteolyt
activ
sarscov
target
cell
hypothes
minim
furin
cleavag
site
rxxr
posit
might
contribut
sarssdepend
membran
fusion
allow
sarss
cleavag
albeit
low
effici
investig
role
motif
sarssdriven
entri
assess
viru
allow
bind
intern
cell
pretreat
mm
ammonium
chlorid
subsequ
cell
treat
tpcktrypsin
activ
sarss
membran
fusion
result
present
percentag
trypsin
ammonium
chlorid
control
mean
standard
deviat
triplic
well
similar
result
seen
cell
optim
minim
furin
cleavag
site
exchang
result
sequenc
rxrr
fig
affect
sarss
function
fluorescenceactiv
cell
sort
analysi
reveal
sarss
mutant
wt
sarss
express
compar
level
surfac
transfect
cell
could
thu
directli
compar
function
studi
supplementari
fig
first
determin
substitut
affect
sproteindriven
infecti
entri
order
assess
infecti
entri
facilit
sprotein
variant
pseudotyp
use
infect
control
cell
fig
left
panel
cell
line
express
endogen
therefor
suscept
sarssdriven
infect
hofmann
et
al
hofmann
et
al
li
et
al
yang
et
al
accordingli
infecti
entri
sarssbear
pseudovirion
control
transfect
cell
detect
fig
left
panel
notabl
entri
driven
variant
effici
infect
driven
sarss
wt
similar
observ
increas
made
infect
cell
examin
fig
left
panel
suggest
augment
sprotein
activ
inde
sarssdriven
membran
fusion
assess
previous
report
cellcel
fusion
assay
hofmann
et
al
measur
fusion
effector
cell
express
sprotein
target
cell
express
sprotein
mutant
activ
sarss
wt
fig
right
panel
thu
introduct
arginin
residu
posit
increas
membran
fusion
activ
sarss
exchang
optim
minim
furin
cleavag
site
sarss
might
increas
sarss
activ
facilit
cleavag
furin
relat
proteas
investig
whether
furin
augment
sarss
activ
determin
infect
sarss
pseudotyp
produc
absenc
presenc
overexpress
furin
fig
left
panel
overexpress
furin
moder
increas
infect
pseudotyp
bear
wt
sarss
mutant
notabl
effect
observ
sarss
wt
pseudotyp
show
augment
infect
fig
left
panel
albeit
increas
statist
signific
compar
observ
made
sdriven
cellcel
fusion
examin
increas
activ
wt
sarss
mutant
observ
upon
furin
overexpress
statist
signific
fig
right
panel
howev
fusion
driven
sarss
wt
augment
similar
degre
fold
furin
overexpress
thu
high
level
furin
enhanc
sarssprotein
driven
cellcel
viruscel
fusion
function
data
show
mutat
overexpress
furin
augment
sarss
activ
presum
facilit
proteolyt
process
sprotein
assess
sarss
cleavag
conduct
western
blot
analys
lysat
sprotein
transfect
cell
use
serum
specif
sarss
express
serv
load
control
result
reveal
promin
band
approxim
kda
wt
sarss
mutant
fig
expect
uncleav
sarss
hofmann
et
al
treatment
cell
trypsin
lysi
reduc
signal
obtain
uncleav
sarss
band
approxim
kda
appear
accord
previous
report
size
sarss
bergeron
et
al
folli
et
al
coexpress
furin
sarss
wt
sprotein
variant
result
appear
indic
furinmedi
cleavag
ineffici
absent
next
investig
whether
exchang
alter
sensit
sarssdepend
membran
fusion
inhibit
cathepsin
l
b
inhibitor
mdl
agreement
publish
data
simmon
et
al
mdl
effici
reduc
infect
sarssbear
pseudotyp
fig
left
panel
similar
inhibit
observ
sarss
mutant
indic
chang
modul
cathepsindepend
viral
entri
stark
contrast
mdl
inhibitori
effect
wt
sarss
depend
cellcel
fusion
fig
right
panel
fig
proteas
activ
virusviru
fusion
mediat
wt
sarss
mutant
pseudovirion
bear
sarss
mix
virionfus
activ
trypsin
cathepsin
l
mock
indic
mock
addit
proteas
mix
particl
addit
control
control
spikeenva
pseudotyp
alon
treat
untreat
proteas
consist
level
detect
previous
describ
simmon
et
al
infect
luciferaseencod
particl
determin
use
luciferas
substrat
describ
manufactur
promega
result
present
mean
standard
deviat
replic
four
well
similar
result
seen
addit
experi
indic
sarssproteindriven
fusion
cellular
membran
depend
cathepsin
activ
sinc
sarssdriven
cellcel
fusion
depend
cathepsinact
ask
activ
proteas
might
requir
first
sought
clarifi
extend
sarssdriven
cellcel
fusion
depend
presenc
exogen
trypsin
sinc
previou
studi
report
effici
sarssdriven
cellcel
fusion
occur
upon
treatment
sarss
express
cell
trypsin
howard
et
al
simmon
et
al
experi
trypsin
dispens
robust
cellcel
fusion
fig
examin
fusion
sarss
vsvg
transfect
cell
control
transfect
cell
express
low
level
endogen
hofmann
et
al
li
et
al
simmon
et
al
found
trypsin
treatment
requir
sarssbut
vsvgdriven
cellcel
fusion
fusion
driven
vsvg
sarss
induc
low
ph
fig
howev
cellcel
fusion
transfect
cell
examin
robust
sarssdriven
fusion
alreadi
observ
absenc
trypsin
treatment
fusion
activ
augment
presenc
trypsin
fig
thu
sarssdriven
cellcel
fusion
depend
trypsinactiv
sarss
receptor
level
limit
express
high
level
robust
fusion
occur
absenc
trypsin
like
due
sarss
activ
host
cell
proteas
cathepsin
order
investig
need
host
cell
proteas
trypsinindepend
sarssdriven
cellcel
fusion
inhibit
wt
sarssdriven
cellcel
fusion
reaction
leupeptin
inhibitor
cystein
serin
proteas
aebsf
serin
proteas
inhibitor
cathepsin
inhibitor
inhibitor
use
noncytotox
concentr
determin
commerci
avail
cytotox
assay
promega
madison
usa
lack
inhibit
luciferas
express
cell
cotransfect
report
plasmid
employ
quantifi
cellcel
fusion
supplementari
fig
inhibitor
test
leupeptin
inhibit
sarssdriven
cellcel
fusion
inhibit
dosedepend
fig
final
leupeptin
inhibit
sarssdriven
viruscel
fusion
fig
expect
result
shown
fig
previou
work
simmon
et
al
thu
sarssdriven
cellcel
fusion
depend
activ
far
uncharacter
cystein
serin
proteas
viruscel
fusion
requir
cathepsin
activ
process
sarss
cellular
proteas
might
determin
rout
effici
viral
entri
target
cell
might
import
consequ
develop
prevent
therapeut
strategi
belouzard
et
al
simmon
et
al
watanab
et
al
howev
site
sarss
recogn
host
cell
proteas
incomplet
defin
show
defin
trypsin
sensit
site
requir
inactiv
cellfre
viru
trypsin
trypsindepend
infecti
entri
cellbound
viru
target
pretreat
ammonium
chlorid
contrast
integr
dispens
infecti
entri
cell
cultur
activ
sarssdriven
virusviru
fusion
trypsin
cathepsin
l
optim
exist
minim
furin
cleavag
site
mutat
augment
sarssdriven
cellcel
viruscel
fusion
howev
evid
cleavag
sarss
motif
obtain
final
differenti
blockad
sarssdriven
viruscel
cellcel
fusion
proteas
inhibitor
show
process
depend
differ
activ
proteas
far
poorli
character
serin
cystein
proteas
respons
sarssdriven
cellcel
fusion
spike
protein
sarscov
contain
sever
potenti
proteas
sensit
site
implic
proteolyt
process
sarss
belouzard
et
al
bergeron
et
al
folli
et
al
ntermin
motif
amino
acid
show
similar
cleavag
site
coronaviru
sprotein
compris
rxxr
motif
recogn
proprotein
convertas
context
cleavabl
coronaviru
sprotein
folli
et
al
nevertheless
mutat
report
block
increas
sarss
membran
fusion
activ
observ
wt
sarss
upon
furin
overexpress
introduct
furin
consensu
sequenc
site
shown
increas
sarssdriven
cellcel
fusion
belouzard
et
al
folli
et
al
result
demonstr
site
import
sarss
cleavag
trypsin
trypsin
cleavag
depend
presenc
thu
cellfre
virion
bear
wt
sarss
sarss
mutant
inactiv
trypsin
cellbound
virion
bear
wt
sarss
mutant
activ
trypsin
infect
ammonium
chlorid
pretreat
target
cell
trypsin
bypass
find
agreement
publish
work
belouzard
et
al
folli
et
al
highlight
defin
proteas
sensit
site
sarss
unexpectedli
howev
mutat
compat
robust
sarss
activ
trypsin
cathepsin
l
virionvirion
fusion
assay
reason
differenti
requir
trypsin
bypass
virionvirion
fusion
assay
present
unclear
might
relat
differ
properti
target
cell
membran
rel
virion
membran
term
receptor
concentr
presenc
cellular
proteas
regardless
underli
mechan
present
data
suggest
might
dispens
activ
sarscov
trypsin
cathepsin
l
scenario
would
agreement
result
bosch
colleagu
map
cathepsin
l
cleavag
site
sarss
amino
acid
bosch
et
al
belouzard
et
al
suggest
proteolyt
activ
sarss
might
twostep
process
might
involv
cleavag
belouzard
et
al
evid
import
role
proteolyt
activ
sarss
obtain
cellcel
fusion
trypsin
bypass
experi
sarss
mutant
found
refractori
activ
trypsin
belouzard
et
al
addit
insert
furin
consensu
motif
site
increas
sarss
activ
cellcel
fusion
assay
belouzard
et
al
document
independ
studi
allow
cathepsinindepend
infecti
entri
target
cell
watanab
et
al
notabl
minim
furin
cleavag
site
rxxr
present
sarss
amino
acid
peptid
span
motif
previous
shown
cleav
furin
peptid
span
recogn
proteas
bergeron
et
al
found
optim
minim
furin
site
posit
mutant
significantli
increas
sarss
activ
cellcel
viruscel
fusion
assay
note
viruscel
fusion
activ
wt
sarss
mutant
augment
overexpress
furin
virusproduc
cell
although
effect
statist
signific
result
suggest
amino
acid
might
constitut
altern
process
site
might
recogn
proprotein
convertas
relat
enzym
howev
proteolyt
process
wt
sarss
variant
upon
furin
overexpress
could
demonstr
indic
cleavag
ineffici
absent
therefor
altern
scenario
role
amino
acid
sarss
activ
must
consid
thu
possibl
augment
sarss
activ
upon
furin
overexpress
mutat
separ
effect
potenti
modul
proteas
sensit
site
sarss
cell
cell
fusion
assay
commonli
use
function
analyz
sarss
includ
character
potenti
proteolyt
process
site
sarss
belouzard
et
al
folli
et
al
hofmann
et
al
simmon
et
al
studi
sarssdriven
cellcel
fusion
examin
upon
activ
sarss
exogen
trypsin
howev
far
determin
sarssdriven
cellcel
fusion
also
activ
host
cell
proteas
instanc
unknown
proteas
respons
proteolyt
activ
virusassoci
sarss
cathepsin
b
l
also
activ
cellassoci
sarss
found
trypsinactiv
sarss
requir
fusion
cell
express
low
amount
fusion
target
cell
express
high
level
proceed
effici
absenc
trypsin
agreement
recent
studi
glowacka
et
al
latter
condit
cellcel
fusion
driven
sarss
inhibit
leupeptin
cathepsin
inhibitor
indic
serin
proteas
cystein
proteas
cathepsin
b
l
activ
sarss
cellcel
fusion
ident
respons
proteas
present
unclear
role
factor
xa
serin
proteas
suggest
result
await
conform
du
et
al
type
ii
transmembran
serin
proteas
ttsp
activ
influenza
viru
hemagglutinin
cleavag
et
al
chaipan
et
al
proteas
recent
shown
also
activ
sarss
membran
fusion
glowacka
et
al
matsuyama
et
al
shulla
et
al
howev
appreci
express
detect
cell
previou
studi
bertram
et
al
sarssdriven
cellcel
fusion
inhibit
serin
proteas
inhibitor
aebsf
present
studi
shown
activ
ttsp
beliveau
et
al
therefor
ttsp
relat
serin
proteas
unlik
account
sarss
activ
condit
test
futur
studi
focu
role
cystein
proteas
express
plasmid
pcaggssarss
encod
spike
protein
sarscov
strain
frankfurt
hofmann
et
al
urbani
simmon
et
al
encod
human
receptor
describ
previous
hofmann
et
al
hofmann
et
al
sitedirect
mutagenesi
sarssprotein
perform
overlapextens
pcr
gener
mutat
follow
overlap
primer
use
sarss
sarss
facilit
gener
pcr
fragment
bear
desir
mutat
prime
portion
ssequenc
amplifi
use
overlap
pcr
subsequ
pcramplifi
fragment
introduc
pcagg
variant
harbour
correspond
portion
sarss
sequenc
variant
kptkr
ept
gener
use
quikchang
site
direct
mutagenesi
stratagen
sarss
pcdna
templat
transfer
pcagg
pcr
amplifi
sequenc
confirm
autom
sequenc
analysi
cell
propag
dulbecco
modifi
eagl
medium
dmem
supplement
fetal
bovin
serum
fb
penicillin
streptomycin
grown
humifi
atmospher
co
cell
stabli
express
gener
transfect
plasmid
hofmann
et
al
cell
follow
select
resist
cell
zeocin
invitrogen
surfac
express
clonal
cell
confirm
fac
analysi
analysi
cellcel
fusion
effector
cell
seed
plate
well
capo
cotransfect
plasmid
encod
herp
simplex
transactiv
fuse
dna
bind
domain
yeast
transcript
factor
stamming
et
al
plasmid
encod
sarssvari
empti
plasmid
furin
empti
plasmid
parallel
target
cell
seed
plate
well
transfect
express
plasmid
togeth
plasmid
luciferas
report
gene
express
control
five
bind
site
stamming
et
al
day
transfect
effector
cell
dilut
fresh
medium
ad
target
cell
cellcel
fusion
quantifi
determin
luciferas
activ
cell
lysat
h
cocultiv
use
commerci
avail
kit
promega
madison
usa
result
gener
experiment
system
describ
earlier
shown
fig
altern
cellcel
fusion
assay
use
fragment
previous
describ
hiv
holland
et
al
effector
cell
cotransfect
plasmid
encod
sarss
vsvg
plasmid
encod
ntermin
fragment
galactosidas
aminoacid
term
peptid
target
cell
cotransfect
plasmid
encod
correspond
empti
plasmid
plasmid
encod
remain
ctermin
portion
aminoacid
term
fragment
day
transfect
effector
cell
dilut
fresh
medium
ad
target
cell
ratio
one
hour
incub
attach
bind
cell
wash
serumfre
medium
puls
medium
adjust
contain
tpcktrypsin
min
ph
trypsin
neutral
addit
excess
medium
contain
serum
trypsin
inhibitor
cell
incub
h
upon
viral
envelopedriven
membran
fusion
peptid
fragment
transcompl
give
function
enzymat
activ
detect
cell
lysat
employ
commerci
avail
kit
galacton
plu
substrat
appli
biosystem
result
gener
experiment
system
shown
fig
gener
lentivir
pseudoparticl
capo
transfect
perform
describ
hofmann
et
al
simmon
et
al
brief
cell
transient
cotransfect
erluc
connor
et
al
express
plasmid
sarssvari
vsvg
experi
human
furin
coexpress
product
pseudoparticl
cultur
medium
replac
h
harvest
h
post
transfect
supernat
pass
filter
aliquot
store
capsid
content
harvest
supernat
determin
use
commerci
avail
kit
murex
wiesbaden
germani
infect
cell
cell
transient
transfect
cell
stabli
express
incub
pseudotyp
normal
infect
protein
content
three
day
cell
lyse
luciferas
activ
determin
use
commerci
avail
kit
promega
madison
usa
cell
preincub
cathepsin
l
b
inhibitor
mdl
calbiochem
darmstadt
germani
min
thereaft
pseudotyp
compar
infect
ad
h
cultur
medium
replac
luciferas
activ
cell
extract
determin
h
describ
earlier
infect
normal
pseudovirion
bear
wildtyp
mutant
sarss
protein
incub
vari
amount
proteas
min
room
temperatur
proteolysi
halt
addit
equal
volum
medium
contain
fb
soy
bean
trypsin
inhibitor
sti
aprotinin
viru
plate
cell
spin
infect
min
rpm
incub
h
medium
replac
fresh
medium
cell
incub
h
measur
luciferas
activ
proteas
obtain
sigma
final
concentr
use
assay
determin
preliminari
experi
maxim
practic
level
achiev
base
stock
solut
mgml
proteas
dilut
pb
trypsin
chymotrypsin
use
final
concentr
elastas
factor
xa
thermolysin
thrombin
plasmin
trypsin
bypass
experi
perform
describ
simmon
et
al
briefli
cell
pretreat
h
cold
medium
contain
ammonium
chlorid
mm
equal
volum
dilut
cold
pseudovirion
mixtur
viru
ultracentrifugeconcentr
resuspend
pb
remov
fb
ad
cell
spininfect
allow
virusbind
cell
medium
replac
warm
serumfre
medium
contain
ammonium
chlorid
mm
incub
min
subsequ
medium
remov
fresh
medium
contain
tpcktrypsin
ad
min
trypsincontain
medium
remov
medium
supplement
sti
ml
ammonium
chlorid
mm
ad
h
incub
period
medium
replac
fresh
medium
without
ammonium
chlorid
cell
incub
h
luciferas
activ
measur
viru
viru
fusion
assay
describ
simmon
et
al
briefli
equal
amount
pseudovirion
bear
either
encod
luciferas
report
hivluc
sarscov
spike
mutant
avian
sarcoma
leukosi
virusa
envelop
encod
gfp
hivgfp
e
mix
incub
min
ice
allow
bind
temperatur
rais
min
allow
induct
conform
rearrang
particl
either
treat
ugml
tpcktrypsin
sigma
ph
lower
ph
addit
citric
acid
preactiv
recombin
cathepsin
l
ad
final
concentr
ugml
proteolysi
halt
min
addit
soybean
trypsin
inhibitor
leupeptin
viru
mixtur
dilut
use
infect
hela
cell
stabli
express
tva
pretreat
leupeptin
h
cell
transient
express
sarss
vlp
harbour
sarss
lyse
sdslaemmli
buffer
boil
min
sampl
separ
via
sdspage
transfer
onto
nitrocellulos
membran
schleicher
schuell
dassel
germani
sarss
protein
detect
stain
sarss
specif
rabbit
serum
imgenex
san
diego
usa
dilut
follow
detect
bound
antibodi
use
peroxidaseconjug
antirabbit
igg
dianova
hamburg
germani
dilut
load
control
strip
membran
incub
antibodi
sigma
deisenhofen
germani
dilut
follow
incub
peroxidaseconjug
antimous
igg
dianova
hamburg
germani
dilut
chemiluminesc
detect
perform
employ
commerci
avail
kit
accord
manufactur
protocol
ecl
western
detect
kit
amersham
pharmacia
biotech
europ
freiburg
germani
statist
signific
calcul
employ
twotail
student
ttest
depend
sampl
supplementari
materi
relat
articl
found
onlin
